Loading...

Home
Stock
0013

0013 News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Forecast Technical Valuation Financials Earnings News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
News Release

Market

Market Analysis
Crypto
Market Movers
Stock Monitor
All US Stocks

Strategies

AI Stock Picker
Swing Trading
QuantAI Alpha Pick
CoinSwing
Daytrading Radar
Crypto Radar
Char Pattern Detection

Resource

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat with Tia
AI Screener
Backtesting Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Option Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Monitor News

Compare

TradingView
Seeking Alpha

0013 News

UPDATE -- Global Firms to Present Live Webcasts at Deutsche Bank’s Virtual Investor Conference for Depositary Receipts on November 4, 2025

Oct 31 2025Globenewswire

Global Firms to Present Live Webcasts at Deutsche Bank's Virtual Investor Conference for Depositary Receipts on November 4, 2025

Oct 30 2025Globenewswire

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

Sep 26 2024Globenewswire

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024

Sep 17 2024Globenewswire

HUTCHMED Highlights Presentation of Phase III Data on Fruquintinib in Second-Line Gastric Cancer at ASCO Plenary Series Session

Feb 06 2024businesswire

HUTCHMED Announces that Inmagene Exercises Option to License Two Drug Candidates as Part of Strategic Partnership

Feb 01 2024businesswire

HUTCHMED to Announce 2023 Final Results

Jan 31 2024businesswire

HUTCHMED Receives ELUNATE® (fruquintinib) Marketing Approval in Hong Kong for Treatment of Metastatic Colorectal Cancer

Jan 29 2024businesswire

0013 Events

an image of No data

No data

0013 Monitor News

an image of No data

No data

0013 Earnings Analysis

an image of No Data

No Data

People Also Watch